Alicia Walls
Developmental - Behavioral Pediatrics · Sugar Land, TXNPI 1124373501
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Corium, LLC at 27.9% of the total. Among developmental - behavioral pediatrics clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 147 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$818
- UCB, Inc.$453
- Supernus Pharmaceuticals, Inc.$356
- Collegium Pharmaceutical, Inc.$265
- Ironshore Pharmaceuticals Inc.$158
- Sumitomo Pharma America, Inc.$142
- plus $742 from 19 others
What the payments were for
- Food & beverage$2,934100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 47 | $818 |
| UCB, Inc. | 22 | $453 |
| Supernus Pharmaceuticals, Inc. | 8 | $356 |
| Collegium Pharmaceutical, Inc. | 16 | $265 |
| Ironshore Pharmaceuticals Inc. | 9 | $158 |
| Sumitomo Pharma America, Inc. | 9 | $142 |
| Tris Pharma Inc | 6 | $129 |
| Jazz Pharmaceuticals Inc. | 4 | $118 |
| Sunovion Pharmaceuticals Inc. | 5 | $71 |
| SK Life Science, Inc. | 2 | $47 |
| Neurelis, Inc. | 1 | $47 |
| Shire North American Group Inc | 2 | $41 |
| Merck | 3 | $39 |
| Quidel Corporation | 1 | $34 |
| Cranial Technologies, Inc | 2 | $32 |
| PTC Therapeutics, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Aquestive Therapeutics, Inc. | 1 | $20 |
| Aprecia Pharmaceuticals, LLC | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Mission Pharmacal Company | 1 | $14 |
| Acadia Pharmaceuticals Inc | 1 | $13 |
| Cumberland Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,934 in reported general payments places this provider in the 95th percentile of 35 developmental - behavioral pediatrics providers in Texas.
See all developmental - behavioral pediatrics providers in Texas →
Other developmental - behavioral pediatrics in Sugar Land
- Patricia HarkinsShavano Park$5K
- Jeri PenkavaSan Antonio$2K
- Holly HarrisHouston$2K
- Anacani FonsecaEl Paso$2K
- James PhalenSan Antonio$2K
- Barbara Kiersz MuellerLakeway$1K
- Gabriel AnzuetoHouston$1K
- Maricela GulbronsonCorpus Christi$1K
- Karen RogersLubbock$1K
- Sheri RavenscroftAustin$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.